HIV-AIDS
Anthony S. Fauci was joined by Harold Phillips, director of the White House Office of National AIDS Policy, as well as senior HIV/AIDS officials from seven states — Arizona, California, Indiana, Iowa, Maryland, Mississippi, and Tennessee — and the District of Columbia for the GW School of…
The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1…
Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction, impacting the longevity and quality of…
Researchers at the GW School of Medicine and Health Sciences received a pair of grants totaling more than $816,000 from Gilead Science, Inc., in support of an 18-month research informed educational initiative, Two in One: HIV+COVID Screening and Testing Model, to study pairing routinize HIV…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) was recently awarded a National Institutes of Health (NIH) T-32 research training grant. The five-year grant, worth nearly $1 million overall, will support the training of junior scientists who will advance research…
Michael Bukrinsky, MD, PhD, professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, is conducting two studies focusing on HIV-associated disorders, with the support of grants from the National Institutes of Health.…
A team of researchers from the George Washington University (GW) has been selected as one of five sites participating in the HIV Prevention Trials Network (HPTN) INTEGRA study (HPTN 094).
The George Washington University (GW), in collaboration with Whitman Walker Institute (WWI), was selected by the National Institute of Allergy and Infectious Diseases (NIAID) to receive an $8.4 million, seven‐year award as part of a significant investment in infrastructure and expertise in support…
The National Institutes of Health has awarded $1.6 million to researchers at SMHS for research on hormonal control of HIV latency.
Alberto Bosque, PhD, MBA, assistant professor of microbiology, immunology, and tropical medicine, and his research team published in PLOS Pathogens finding a multiple sclerosis drug may be used to block HIV infection and reduce the latent reservoir.